On August 19, 2026, Novartis AG NVS shares rose 3.7% to $160.31, continuing a positive trend that has seen the stock increase by 19.8% year-to-date and 32.2% over the past year. The shares have fluctuated between a 52-week low of $121.57 and a high of $170.46.
- GF Valueâ„¢ verdict: Current price is $160.31 vs GF Valueâ„¢ of $130.44, indicating the stock is 22.9% overvalued.
- GF Scoreâ„¢: 79/100, reflecting an above-average rating.
- Most notable signal: No insider transactions in the past 12 months.
Is NVS Overvalued or Undervalued?
Currently, Novartis AG's shares are trading at $160.31, which is significantly above the GF Valueâ„¢ estimate of $130.44. This suggests that the stock is approximately 22.9% overvalued. The GF Valueâ„¢ is GuruFocus' intrinsic value estimate derived from an analysis of historical trading multiples, past business growth, and future performance predictions. Given that the stock is marked as "Modestly Overvalued," investors should be cautious as the current valuation does not provide a significant margin of safety.
Investors looking at Novartis AG may need to consider the implications of this overvaluation. A stock trading above its intrinsic value can indicate heightened risk, particularly in volatile market conditions. While the company has shown robust performance metrics in the past, the current price may not justify new investments without a compelling growth narrative or significant catalysts to drive future earnings.
How Does NVS's Valuation Compare to Its History?
| Metric | Current | Historical |
|---|---|---|
| P/E (TTM) | 24.2x | 17.0x (5-Year Median) |
| Forward P/E | 18.2x | N/A |
Currently, Novartis AG's trailing P/E ratio of 24.2x is significantly higher than its 5-year median of 17.0x, reflecting a 42% premium. This elevated P/E ratio aligns with the GF Valueâ„¢ verdict that the stock is overvalued, reinforcing the notion that the stock may be trading at a premium to its historical valuation metrics.
What Does NVS's GF Scoreâ„¢ Tell Us?
The GF Scoreâ„¢ evaluates a company's financial strength, profitability, growth potential, valuation, and momentum to offer a comprehensive picture of its overall quality. Novartis AG's GF Scoreâ„¢ of 79/100 is indicative of a solid company, with notable strengths in its profitability and momentum ranks, although it has some weaknesses in financial strength and growth.
| Metric | Rating |
|---|---|
| GF Scoreâ„¢ | 79 |
| Financial Strength | 5/10 |
| Profitability | 7/10 |
| Growth | 6/10 |
| Valuation | 6/10 |
| Momentum | 9/10 |
Overall, Novartis AG demonstrates a strong momentum rank of 9/10, suggesting it has performed well in the market recently. However, the financial strength rank of 5/10 indicates some concerns regarding its balance sheet. Additionally, the profitability rank of 7/10 shows that while the company is generating profits, there is room for improvement.
What Are Gurus and Insiders Doing with NVS?
Currently, 18 gurus hold shares of Novartis AG, with 6 increasing their positions and 11 trimming their stakes in recent quarters. This mixed activity among gurus suggests a divided sentiment on the stock, with some investors seeing value while others may be taking profits or reassessing their positions. The lack of insider transactions in the past 12 months may indicate that insiders are not actively buying or selling, which could reflect their confidence in the current valuation or a wait-and-see approach regarding future growth prospects.
What This Means for Investors
Considering the GF Valueâ„¢ assessment, Novartis AG appears to be overvalued at its current price of $160.31, trading well above its intrinsic value of $130.44. While the company's momentum and profitability are commendable, potential investors should weigh this against the risk associated with a high valuation and the mixed signals from guru activity. For those interested in Novartis, it may be prudent to keep an eye on price adjustments or upcoming developments that could enhance the stock's value proposition.
For a more detailed analysis, visit the Novartis AG NVS stock page or check out the GF Valueâ„¢ page.
Frequently Asked Questions
What is NVS's GF Scoreâ„¢?
NVS's GF Scoreâ„¢ is 79/100, which indicates that the company is performing above average in its sector based on multiple financial metrics.
Is NVS overvalued or undervalued?
NVS is currently overvalued, with a GF Valueâ„¢ of $130.44 compared to its market price of $160.31.
What is NVS's P/E ratio?
NVS's P/E ratio is 24.2x, which is 42% above its 5-year median of 17.0x, indicating a premium valuation compared to its historical averages.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
